LEVAMISOLE EXACERBATES COXSACKIE-VIRUS B3-INDUCED MURINE MYOCARDITIS

[1] VIRAL MYOCARDITIS AND ITS SEQUELAE [J]. ANNUAL REVIEW OF MEDICINE, 1973, 24 : 145 - 152

[2] LEVAMISOLE AND IMMUNOTHERAPY - SOME THEORETIC AND PRACTICAL CONSIDERATIONS AND THEIR RELEVANCE TO HUMAN-DISEASE [J]. ONCOLOGY, 1981, 38 (03) : 168 - 181

[3] AMERY WK, 1978, J RETICULOENDOTH SOC, V24, P187

[4] AN EXTENSION OF 51CR-RELEASE ASSAY FOR ESTIMATION OF MOUSE CYTOTOXINS [J]. TRANSPLANTATION, 1968, 6 (06) : 761 - &

[5] ROLE OF VIRUSES IN PRODUCTION OF HEART-DISEASE [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1972, 29 (02) : 231 - +

[6] LYMPHOCYTE SORTING ON ALBUMINATED CIBA BLUE DEXTRAN-STAPHYLOCOCCAL PROTEIN A-CONJUGATED SEPHAROSE 6MB AFFINITY COLUMNS [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1981, 45 (02) : 137 - 151

[7] TEMPERATURE-SENSITIVE MUTANT OF COXSACKIEVIRUS-B3 ESTABLISHED RESISTANCE IN NEONATAL MICE THAT PROTECTS THEM DURING ADOLESCENCE AGAINST COXSACKIEVIRUS-B3-INDUCED MYOCARDITIS [J]. INFECTION AND IMMUNITY, 1983, 39 (02) : 851 - 864

[8] PROPERTIES OF COXSACKIE-VIRUS B3 VARIANTS WHICH ARE AMYOCARDITIC OR MYOCARDITIC FOR MICE [J]. JOURNAL OF MEDICAL VIROLOGY, 1979, 3 (03) : 207 - 220

[9] GOMEZ MP, 1980, P SOC EXP BIOL MED, V165, P107

[10] HADDEN JW, 1977, IMMUNOPHARMACOLOGY, P279

[1] VIRAL MYOCARDITIS AND ITS SEQUELAE [J]. ANNUAL REVIEW OF MEDICINE, 1973, 24 : 145 - 152

[2] LEVAMISOLE AND IMMUNOTHERAPY - SOME THEORETIC AND PRACTICAL CONSIDERATIONS AND THEIR RELEVANCE TO HUMAN-DISEASE [J]. ONCOLOGY, 1981, 38 (03) : 168 - 181

[3] AMERY WK, 1978, J RETICULOENDOTH SOC, V24, P187

[4] AN EXTENSION OF 51CR-RELEASE ASSAY FOR ESTIMATION OF MOUSE CYTOTOXINS [J]. TRANSPLANTATION, 1968, 6 (06) : 761 - &

[5] ROLE OF VIRUSES IN PRODUCTION OF HEART-DISEASE [J]. AMERICAN JOURNAL OF CARDIOLOGY, 1972, 29 (02) : 231 - +

[6] LYMPHOCYTE SORTING ON ALBUMINATED CIBA BLUE DEXTRAN-STAPHYLOCOCCAL PROTEIN A-CONJUGATED SEPHAROSE 6MB AFFINITY COLUMNS [J]. JOURNAL OF IMMUNOLOGICAL METHODS, 1981, 45 (02) : 137 - 151

[7] TEMPERATURE-SENSITIVE MUTANT OF COXSACKIEVIRUS-B3 ESTABLISHED RESISTANCE IN NEONATAL MICE THAT PROTECTS THEM DURING ADOLESCENCE AGAINST COXSACKIEVIRUS-B3-INDUCED MYOCARDITIS [J]. INFECTION AND IMMUNITY, 1983, 39 (02) : 851 - 864

[8] PROPERTIES OF COXSACKIE-VIRUS B3 VARIANTS WHICH ARE AMYOCARDITIC OR MYOCARDITIC FOR MICE [J]. JOURNAL OF MEDICAL VIROLOGY, 1979, 3 (03) : 207 - 220

[9] GOMEZ MP, 1980, P SOC EXP BIOL MED, V165, P107

[10] HADDEN JW, 1977, IMMUNOPHARMACOLOGY, P279